SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001372514-24-000020
Filing Date
2024-02-28
Accepted
2024-02-28 16:40:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3xfebruary2024.htm S-3 334457
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 33783
3 EX-5.1 exhibit51-sx3.htm EX-5.1 14169
4 EX-23.1 exhibit231-sx3.htm EX-23.1 3487
5 BURNS LOGO image.jpg GRAPHIC 27194
6 image_2a.jpg GRAPHIC 24177
  Complete submission text file 0001372514-24-000020.txt   458056
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277460 | Film No.: 24696220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)